CCCCCCCCCCCCOS()(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 claims description 3 DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound.239000006186 oral dosage form Substances 0.000 claims abstract description 3.239000007787 solid Substances 0.000 claims abstract description 4.239000008194 pharmaceutical composition Substances 0.000 claims abstract description 7.239000002202 Polyethylene glycol Substances 0.000 claims abstract description 48.229920001223 polyethylene glycol Polymers 0.000 claims abstract description 49.229960002626 clarithromycin Drugs 0.000 claims abstract description 69.AGOYDEPGAOXOCK-KCBOHYOISA-N clarithromycin Chemical compound AGOYDEPGAOXOCK-KCBOHYOISA-N 0.000 claims abstract description 69.229960004287 clofazimine Drugs 0.000 claims abstract description 73.WDQPAMHFFCXSNU-BGABXYSRSA-N Clofazimine Chemical compound C12=CC=CC=C2N=C2C=C(NC=3C=CC(Cl)=CC=3)C(=N/C(C)C)/C=C2N1C1=CC=C(Cl)C=C1 WDQPAMHFFCXSNU-BGABXYSRSA-N 0.000 claims abstract description 73.229960000885 rifabutin Drugs 0.000 claims abstract description 74.ATEBXHFBFRCZMA-VXTBVIBXSA-N RIFABUTIN Chemical compound ATEBXHFBFRCZMA-VXTBVIBXSA-N 0.000 claims abstract description 74.206010021972 Inflammatory bowel disease Diseases 0.000 title description 10.239000000203 mixture Substances 0.000 title claims description 116.Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.) Filing date Publication date Priority claimed from US6514408P external-priority Application filed by RED HILL BIOPHARMA Ltd filed Critical RED HILL BIOPHARMA Ltd Application granted granted Critical Publication of ES2708087T3 publication Critical patent/ES2708087T3/en Status Active legal-status Critical Current Anticipated expiration legal-status Critical Links Original Assignee RED HILL BIOPHARMA Ltd Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.) Inventor Thomas Julius Borody Patrick Gosselin Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.) Active Application number ES09708397T Other languages Spanish ( es) Procedures and compositions for treating inflammatory bowel diseaseÄownload PDF Info Publication number ES2708087T3 ES2708087T3 ES09708397T ES09708397T ES2708087T3 ES 2708087 T3 ES2708087 T3 ES 2708087T3 ES 09708397 T ES09708397 T ES 09708397T ES 09708397 T ES09708397 T ES 09708397T ES 2708087 T3 ES2708087 T3 ES 2708087T3 Authority ES Spain Prior art keywords rifabutin clofazimine clarithromycin abc peg Prior art date Legal status (The legal status is an assumption and is not a legal conclusion.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |